Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
(2025, December 9)
MET-233i, a monthly dosing, ultra-long acting, subcutaneously injectable amylin analog candidate being evaluated as monotherapy and in combination with MET-097i in a Phase I trial
It will take years to match what semaglutide has established
In the case of a GLP-1 receptor agonist like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), microdosing refers to taking lower than the labeled dose
But the world of GLP-1 research was just getting going
Women of childbearing age are typically required to use effective contraception and test negative for pregnancy before starting it
US$ 23.38
US$ 20.19
US$ 22.07
